Meaghan Loy

In a landmark move toward modernizing nonclinical drug evaluation, the FDA recently issued new draft guidance that identifies specific product...

Recently, the U.S. Food and Drug Administration (FDA) announced a historic shift in its approach to drug testing, planning to phase out the...

This blog post was written by Meaghan Loy, MS, ALAT our Senior Category Director of In Vivo and GLP Services here at Scientist.com. Meaghan has...

Meaghan Loy, Category Director of In Vivo Services at Scientist.com and member of the North American 3Rs Collaborative Board of Directors...

At Scientist.com, we take our commitment to animal welfare very seriously. Whether through due diligence, compliance or education, we support...

There are as many ways to create in vivo proposals on the Scientist.com marketplace as there are researchers to request them, so how do we ensure...